No menu items!

Five projects vie to become Brazil’s first national vaccine against Covid-19

RIO DE JANEIRO, BRAZIL - Butanvac, which is being developed at the Butantan Institute and is already being tested in humans, is ahead in the race among some of Brazil's largest research institutions to find a national immunizing agent against Covid-19.

More than ten projects are underway across the country, five of which are more advanced. In addition to Butanvac, products from three federal research universities - UFRJ in Rio de Janeiro; UFMG in Belo Horizonte, Minas Gerais; and USP of Ribeirão Preto, São Paulo - are awaiting ANVISA (national health regulator) approval to begin clinical trials; UFPR in . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content